Paper10692049
Inhibition of contact sensitivity in human CD4+ transgenic mice by human CD4-specific monoclonal antibodies: CD4+ T-cell depletion is not required.
Podolin PL and 4 others. Immunology, 2000. Cited by 11 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Inhibition of contact sensitivity in human CD4+ transgenic mice by human CD4-specific monoclonal antibodies: CD4+ T-cell depletion is not required. Papers, record 10692049. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10692049
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibition of contact sensitivity in human CD4+ transgenic mice by human CD4-specific monoclonal antibodies: CD4+ T-cell depletion is not required.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CD4-Positive T-Lymphocytes | Major topic |
| Dermatitis, Contact | Major topic |
| Adjuvants, Immunologic | |
| Animals | |
| Antibodies, Monoclonal | |
| CD4 Antigens | |
| Dose-Response Relationship, Immunologic | |
| Humans | |
| Immune Tolerance | |
| Interferon-gamma | |
| Interleukin-4 | |
| Mice | |
| Mice, Transgenic | |
| Oxazolone |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7,673,704 | Paradoxical IgA immunity in CD4-deficient mice. Lack of cholera toxin-specific protective immunity despite normal gut mucosal IgA differentiation. | J Immunol | 1995 | https://conductscience.org/library/papers/7673704 | PubMed |
| 2 | 7,821,755 | A structural view of CD4 and CD8. | FASEB J | 1995 | https://conductscience.org/library/papers/7821755 | PubMed |
| 3 | 8,559,607 | Evaluation of the protective efficacy of reshaped human monoclonal antibody RSHZ19 against respiratory syncytial virus in cotton rats. | Pediatr Res | 1995 | https://conductscience.org/library/papers/8559607 | PubMed |
| 4 | 8,575,197 | CD4 and signal transduction. | Curr Top Microbiol Immunol | 1996 | https://conductscience.org/library/papers/8575197 | PubMed |
| 5 | 8,575,199 | The regulation and function of the CD4 coreceptor during T lymphocyte development. | Curr Top Microbiol Immunol | 1996 | https://conductscience.org/library/papers/8575199 | PubMed |
| 6 | 8,596,036 | Mutations in human CD4 impair the functional interaction with different human and mouse class II isotypes and alleles. | J Immunol | 1996 | https://conductscience.org/library/papers/8596036 | PubMed |
| 7 | 8,618,064 | Hyporesponsiveness in contact hypersensitivity and irritant contact dermatitis in CD4 gene targeted mouse. | J Invest Dermatol | 1996 | https://conductscience.org/library/papers/8618064 | PubMed |
| 8 | 8,642,241 | T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells. | J Exp Med | 1996 | https://conductscience.org/library/papers/8642241 | PubMed |
| 9 | 8,805,674 | Induction of Th2 cytokines and control of collagen-induced arthritis by nondepleting anti-CD4 Abs. | J Immunol | 1996 | https://conductscience.org/library/papers/8805674 | PubMed |
| 10 | 9,058,767 | Protection from experimental autoimmune encephalomyelitis (EAE): non-depleting anti-CD4 mAb treatment induces peripheral T-cell tolerance to MBP in PL/J mice. | J Neuroimmunol | 1997 | https://conductscience.org/library/papers/9058767 | PubMed |
| 11 | 9,191,886 | A primatized MAb to human CD4 causes receptor modulation, without marked reduction in CD4+ T cells in chimpanzees: in vitro and in vivo characterization of a MAb (IDEC-CE9.1) to human CD4. | Clin Immunol Immunopathol | 1997 | https://conductscience.org/library/papers/9191886 | PubMed |
| 12 | 9,278,342 | Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile. | J Immunol | 1997 | https://conductscience.org/library/papers/9278342 | PubMed |
| 13 | 9,366,431 | Treatment of a newly established transgenic model of chronic arthritis with nondepleting anti-CD4 monoclonal antibody. | J Immunol | 1997 | https://conductscience.org/library/papers/9366431 | PubMed |
| 14 | 9,665,392 | Intralesional cytokines in chronic oxazolone-induced contact sensitivity suggest roles for tumor necrosis factor alpha and interleukin-4. | J Invest Dermatol | 1998 | https://conductscience.org/library/papers/9665392 | PubMed |
| 15 | 9,798,587 | Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma. | Lancet | 1998 | https://conductscience.org/library/papers/9798587 | PubMed |
| 16 | 10,384,148 | Repeated administration of adenoviral vectors in lungs of human CD4 transgenic mice treated with a nondepleting CD4 antibody. | J Immunol | 1999 | https://conductscience.org/library/papers/10384148 | PubMed |
| 17 | 3,919,141 | Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. | J Exp Med | 1985 | https://conductscience.org/library/papers/3919141 | PubMed |
| 18 | 10,657,642 | Elimination of Fc receptor-dependent effector functions of a modified IgG4 monoclonal antibody to human CD4. | J Immunol | 2000 | https://conductscience.org/library/papers/10657642 | PubMed |
| 19 | 10,944,754 | Measurement of protein interaction bioenergetics: application to structural variants of anti-sCD4 antibody. | Methods Enzymol | 2000 | https://conductscience.org/library/papers/10944754 | PubMed |
| 20 | 6,972,973 | Hapten-specific T cell response to 4-hydroxy-3-nitrophenyl acetyl. X. Characterization of distinct T cell subsets mediating cutaneous sensitivity responses. | J Immunol | 1981 | https://conductscience.org/library/papers/6972973 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31,502,016 | Editorial: A Novel Monoclonal Antibody-Targeting Angiogenesis by Inhibiting Secreted Frizzled-Related Protein 2. | Ann Surg Oncol | 2019 | https://conductscience.org/library/papers/31502016 | PubMed |
| 30,021,009 | Preclinical toxicological assessment of a novel monoclonal antibody targeting human platelet-derived growth factor CC (PDGF-CC) in PDGF-CChum mice. | PLoS One | 2018 | https://conductscience.org/library/papers/30021009 | PubMed |
| 20,065,651 | Preclinical development of monoclonal antibodies: considerations for the use of non-human primates. | MAbs | 2009 | https://conductscience.org/library/papers/20065651 | PubMed |
| 20,046,568 | Practical considerations for nonclinical safety evaluation of therapeutic monoclonal antibodies. | MAbs | 2009 | https://conductscience.org/library/papers/20046568 | PubMed |
| 11,160,000 | Immunomodulatory effects of anti-CD4 antibody in host resistance against infections and tumors in human CD4 transgenic mice. | Infect Immun | 2001 | https://conductscience.org/library/papers/11160000 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10692049
GET https://conductscience.org/api/papers/v1/10692049/references?page=2